Noesis Capital Mangement Corp lessened its stake in Amdocs Limited (NASDAQ:DOX) by 1.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 107,035 shares of the technology company’s stock after selling 1,450 shares during the period. Amdocs comprises approximately 2.4% of Noesis Capital Mangement Corp’s investment portfolio, making the stock its 20th largest holding. Noesis Capital Mangement Corp owned 0.07% of Amdocs worth $7,009,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Delpha Capital Management LLC purchased a new stake in Amdocs in the 4th quarter worth approximately $109,000. Focused Wealth Management Inc purchased a new stake in Amdocs in the 4th quarter worth approximately $157,000. American International Group Inc. purchased a new stake in Amdocs in the 4th quarter worth approximately $199,000. CENTRAL TRUST Co boosted its position in Amdocs by 45.0% in the 4th quarter. CENTRAL TRUST Co now owns 3,388 shares of the technology company’s stock worth $222,000 after purchasing an additional 1,052 shares in the last quarter. Finally, Cerebellum GP LLC purchased a new stake in Amdocs in the 4th quarter worth approximately $246,000. Institutional investors and hedge funds own 93.46% of the company’s stock.
Shares of Amdocs Limited (DOX) traded down $0.11 during mid-day trading on Wednesday, hitting $68.48. The stock had a trading volume of 17,723 shares, compared to its average volume of 689,441. The firm has a market cap of $9,887.58, a P/E ratio of 18.68, a price-to-earnings-growth ratio of 2.35 and a beta of 0.55. Amdocs Limited has a twelve month low of $60.30 and a twelve month high of $71.37.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 20th. Investors of record on Friday, March 30th will be paid a $0.25 dividend. This is an increase from Amdocs’s previous quarterly dividend of $0.22. This represents a $1.00 annualized dividend and a yield of 1.46%. The ex-dividend date is Wednesday, March 28th. Amdocs’s dividend payout ratio is currently 28.39%.
Several research analysts have recently weighed in on DOX shares. BidaskClub raised Amdocs from a “strong sell” rating to a “sell” rating in a research note on Thursday, January 18th. Oppenheimer reaffirmed a “buy” rating and set a $77.00 target price on shares of Amdocs in a research note on Wednesday, January 31st. ValuEngine raised Amdocs from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Stifel Nicolaus upped their target price on Amdocs from $72.00 to $75.00 and gave the stock a “buy” rating in a research note on Wednesday, January 31st. Finally, Zacks Investment Research downgraded Amdocs from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company. Amdocs has a consensus rating of “Hold” and a consensus target price of $70.71.
COPYRIGHT VIOLATION WARNING: “Noesis Capital Mangement Corp Sells 1,450 Shares of Amdocs Limited (DOX)” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.americanbankingnews.com/2018/03/14/noesis-capital-mangement-corp-sells-1450-shares-of-amdocs-limited-dox.html.
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.